EUCOPE News by Tag — Rare Disease

Filtered by Tag: Rare Disease

EUCOPE Resources / News - September 17, 2021

Event report: EUCOPE/IML roundtable ‘Revision of the European Orphan & Paediatric Regulation and impact for the Nordic rare disease community’

EUCOPE, in partnership with the Swedish Industry Association for Small and Medium-Sized Life Sciences Companies (IML), hosted a roundtable on the Revision of the European Orphan & Paediatric Regulation with Nordic stakeholders on 7 September. Over the last 20 years, the orphan and paediatric legislation… read more

EUCOPE Resources / News / Press Releases - July 29, 2021

Response to the OMP & Paediatric Consultation- A Call for a Constructive Conversation

The European Commission is consulting stakeholders as part of its revision process of two major pieces of legislation, on medicines for rare diseases and paediatric patients. Central to the development of innovative treatments for these specific categories of patients, this revision process represents an important… read more

Events & Meetings / News - July 28, 2021

Event Report: EUCOPE/FranceBiotech roundtable ‘OMP Regulation Revision, perspectives of the French rare disease community’

EUCOPE, in partnership with FranceBiotech, hosted a roundtable on the revision of the orphan medicine and paediatric regulations with French stakeholders on 30 June. The orphan and paediatric legislation has considerably accelerated research efforts over the last two decades and has contributed to the development… read more

Partnerships - March 25, 2021


Working group of European rare disease experts developed  nine principles to foster greater consistency in Value Assessment and Funding Process in rare diseases. The group explored the pricing and reimbursement systems for OMPs in selected European countries to analyse where they align with or diverge from… read more